Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Dialysis

Intradermal HBV vaccination is preferable in non-responders

Nature Reviews Nephrology volume 5, pages 616–617 (2009)Cite this article

In patients on hemodialysis with a history of failure to respond to hepatitis B vaccination, intradermal revaccination is more effective than repeat intramuscular vaccination. Intradermal vaccine administration might become the standard of care for high-risk patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Vanholder, R., Van Loo, A., Dohndt, A. M., De Smet, R. & Ringoir, S. Influence of uremia and hemodialysis on host defense and infection. Nephrol. Dial. Transplant. 11, 593–598 (1996).

    Article  CAS  PubMed  Google Scholar 

  2. Caillat-Zucman, S. et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int. 53, 1626–1630 (1998).

    Article  CAS  PubMed  Google Scholar 

  3. Kayataş, M. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients. Artif. Organs 26, 492–496 (2002).

    Article  PubMed  Google Scholar 

  4. Barraclough, K. A. et al. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am. J. Kidney Dis. 54, 95–103 (2009).

    Article  PubMed  Google Scholar 

  5. Propst, T., Propst, A., Lhotta, K., Vogel, W. & König, P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am. J. Kidney Dis. 32, 1041–1045 (1998).

    Article  CAS  PubMed  Google Scholar 

  6. Mat, O., Mestrez, F., Beauwens, R., Muniz-Martinez, M. C. & Dhaene, M. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years. Hemodial. Int. 10, 49–55 (2006).

    Article  PubMed  Google Scholar 

  7. Fabrizi, F., Dixit, V., Magnini, M., Elli, A. & Martin, P. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment. Pharmacol. Ther. 24, 497–506 (2006).

    Article  CAS  PubMed  Google Scholar 

  8. Belshe, R. B. et al. Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med. 351, 2286–2294 (2004).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, University of British Columbia, St Paul's Hospital, Vancouver, BC, Canada

    Adeera Levin

Authors
  1. Adeera Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adeera Levin.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levin, A. Intradermal HBV vaccination is preferable in non-responders. Nat Rev Nephrol 5, 616–617 (2009). https://doi.org/10.1038/nrneph.2009.166

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.166

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing